SEK8.56 0.2 2.6%
Last Trade - 5:00pm
| Market Cap | ÂŁ40.3m |
| Enterprise Value | ÂŁ40.1m |
| Revenue | ÂŁ3.80m |
| Position in Universe | 1139th / 1877 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 20.3 | 4.75 | 8.90 | 22.9 | 33.7 | 40.7 | 59.0 | 99.0 | +14.9% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patient’s head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. It has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Public Since | June 18, 2009 |
| No. of Shareholders: | n/a |
| No. of Employees: | 27 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 55,059,155 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Traktorgranden 3, LUND, 226 60, Sweden |
| Web | http://www.dignitana.com |
| Phone | +46 46 163090 |
| Contact | Mikael Wahlgren (Deputy Managing Director, Director) |
| Auditors | PricewaterhouseCoopers AB |
As of 5:00pm, shares in Dignitana AB are trading at SEK8.56, giving the company a market capitalisation of ÂŁ40.3m. This share price information is delayed by 15 minutes.
Shares in Dignitana AB are currently trading at SEK8.56 and the price has moved by -12.58% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dignitana AB price has moved by -8.71% over the past year.
There are no analysts currently covering Dignitana AB.
Dignitana AB is scheduled to issue upcoming financial results on the following dates:
Dignitana AB does not currently pay a dividend.
Dignitana AB does not currently pay a dividend.
Dignitana AB does not currently pay a dividend.
To buy shares in Dignitana AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Dignitana AB are currently trading at SEK8.56, giving the company a market capitalisation of ÂŁ40.3m.
Here are the trading details for Dignitana AB:
Based on an overall assessment of its quality, value and momentum, Dignitana AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Dignitana AB are currently priced at SEK8.56. At that level they are trading at 37.89% discount to the analyst consensus target price of 0.00.
Analysts covering Dignitana AB currently have a consensus Earnings Per Share (EPS) forecast of -0.64 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dignitana AB. Over the past six months, the relative strength of its shares against the market has been 4.35%. At the current price of SEK8.56, shares in Dignitana AB are trading at 11.32% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Dignitana AB.
Dignitana AB's management team is headed by:
Here are the top five shareholders of Dignitana AB based on the size of their shareholding:
